Santen Pharmaceutical (Japan)
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Shigeo_Taniuchi
|
| gptkbp:country |
gptkb:Japan
|
| gptkbp:founded |
1890
|
| gptkbp:founder |
gptkb:Kenjiro_Nishida
|
| gptkbp:headquarters_location |
gptkb:Osaka,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Santen Pharmaceutical (Japan)
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:listedOn |
gptkb:Nikkei_225
|
| gptkbp:net_sales |
over 200 billion yen (recent years)
|
| gptkbp:numberOfEmployees |
over 4,000
|
| gptkbp:products |
prescription medicines
eye drops ophthalmic drugs |
| gptkbp:servesArea |
worldwide
|
| gptkbp:specializesIn |
ophthalmology
|
| gptkbp:stockExchange |
gptkb:Tokyo_Stock_Exchange
|
| gptkbp:stockSymbol |
4536
|
| gptkbp:subsidiary |
gptkb:Santen_Inc._(USA)
gptkb:Santen_Oy_(Finland) |
| gptkbp:website |
https://www.santen.com/
|
| gptkbp:bfsParent |
gptkb:Bayer_Eylea_(ophthalmology)
|
| gptkbp:bfsLayer |
6
|